Drug Discovery Informatics Market: Market Forecast and Market Growth 2024-2032
The global drug discovery informatics market was valued at USD 2.94 billion in 2021 and is projected to reach USD 6.75 billion by 2028, growing at a CAGR of 12.7% during the forecast period. The Drug Discovery Informatics Market Size captures the rapidly evolving landscape where computational tools and analytics are transforming pharmaceutical research.
As pharmaceutical companies strive to improve the efficiency, speed, and success rates of new drug development, the demand for sophisticated informatics solutions is surging. Drug discovery informatics helps streamline complex data analysis, modeling, and simulation processes, reducing the time and cost associated with bringing a new drug to market. Integration of AI, machine learning, and big data analytics continues to propel this market forward.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/2028
Key Players
- Schrödinger (Maestro)
- PerkinElmer (Signals Notebook and ChemOffice)
- BIOVIA (Dassault Systèmes) (BIOVIA Discovery Studio)
- Benchling (Benchling Platform)
- Genedata (Genedata Screener)
- Thermo Fisher Scientific (Thermo Scientific Compound Discoverer)
- Dotmatics (Dotmatics Platform)
- Aragen Life Sciences (Drug Discovery Informatics Solutions)
- GVK Biosciences (GVK BIO) (GVK BIO Informatics Solutions)
- Molecular Discovery Ltd. (MoKa)
- Lhasa Limited (Derek Nexus)
Key Highlights:
- The market was valued at USD 2.94 billion in 2021 and is expected to grow to USD 6.75 billion by 2028.
- Rising adoption of cloud-based services and AI-driven platforms in drug discovery processes.
- Growing prevalence of chronic diseases fuels demand for faster drug development cycles.
- North America holds a dominant share due to high R&D investments and presence of major pharmaceutical firms.
- Increasing collaboration between biotech firms and academic institutions enhances innovation.
- Workflow optimization in target identification and lead generation driving demand for informatics platforms.
Future Scope:
The future of the drug discovery informatics market looks promising, with advancements in AI, cloud computing, and real-world data integration set to further transform drug development pipelines. The integration of predictive analytics will continue to reduce R&D timelines and costs, allowing researchers to prioritize potential drug candidates more efficiently. Emerging markets in Asia-Pacific are also anticipated to witness significant growth due to increasing healthcare investments and government support for biotech innovation.
Conclusion:
As the pharmaceutical industry evolves to meet complex healthcare demands, drug discovery informatics is poised to play a central role in shaping the future of medicine. With continuous technological advancements and growing global interest in efficient drug development, the market is on a strong upward trajectory toward 2028.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Other Related Reports:
Comments
0 comment